E-Book, Englisch, 531 Seiten, eBook
Yadav / Jain Novel Carrier Systems for Targeted and Controlled Drug Delivery
1. Auflage 2024
ISBN: 978-981-97-4970-6
Verlag: Springer Singapore
Format: PDF
Kopierschutz: 1 - PDF Watermark
E-Book, Englisch, 531 Seiten, eBook
ISBN: 978-981-97-4970-6
Verlag: Springer Singapore
Format: PDF
Kopierschutz: 1 - PDF Watermark
Zielgruppe
Research
Autoren/Hrsg.
Weitere Infos & Material
Chapter 1_ Fundamentals of targeted drug delivery.- Chapter 2_ Influence of drug properties and routes of drug administration on design of sustained and controlled release systems.- Chapter 3_ Polymeric materials in controlled drug delivery.- Chapter 4_ Biopharmaceutic and pharmacokinetic aspects of peroral Controlled Drug Delivery Systems.- Chapter 5_ Parenteral drug delivery.- Chapter 6_ Proteins / peptides drug delivery systems.- Chapter 7_ Transdermal / skin drug delivery system.- Chapter 8_ Implantable Therapeutics Systems.- Chapter 9_ Chemical drug delivery systems.- Chapter 10_ Targeted brain delivery.- Chapter 11_ Targeted Tumor Delivery.- Chapter 12_ Miscellaneous targeting approaches: Fundamentals of gene delivery, Overview of colon, liver, macrophage, mitochondrial and M cells targeting.- Chapter 13_ Overview of Specialized drug delivery systems: Transfersomes, Ethosomes, Layersomes, Bilosomes,Emulsomes, Virosomes, Cubosomes, Aquasomes, Pharmacosomes. Dendrimers, Polymeric Micelles and Resealed Erythrocytes.- Chapter 14_ Controlled release formulations for alternate routes of administration.- Chapter 15_ Stimuli responsive drug delivery systems: Magnetically, thermal and pH-assisted drug delivery systems.- Chapter 16_ Role of controlled release in veterinary formulations.- Chapter 17_ Colloidal drug delivery systems: (a) Liposomes and niosomes.- Chapter 18_ Solid lipid nanoparticles and nanostructured lipid carriers.- Chapter 19_ Polymeric nanoparticles – PLGA, chitosan, albumin, gelatin, alginate etc and Carbon nanotubes.- Chapter 20_ Theranostics Application of Controlled Release Drug Delivery systems.- Chapter 21_ Regulatory approval pathways involved in controlled release formulations.